Equity · Healthcare
EWTX
Edgewise Therapeutics, Inc. · NasdaqGS
The line runs $33 on 20 May through $40 on 17 July, on a scale from $30 to $50. Days the market did not trade hold the previous close, flat.
The chart above plots the price of EWTX over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 40 sessions over that window: $33 on 20 May 2026 through $40 on 17 July 2026.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 18, 2026
EWTX insider trades
EWTX has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 19 November 2025.
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Showing the 12 most recent of 18 compensation filings in this window. The figures above count all of them.
EWTX reported financials
EWTX reported net income of −$167.8M for the fiscal year ended 31 Dec 2025.
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
EWTX earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
EWTX institutional holders
8 of the 45 institutional funds we track reported a EWTX position for the quarter ended 30 Jun 2026 — a combined $187.3M; the latest of those filings landed 14 Aug 2026.
Source: SEC EDGAR 13F filings
EWTX fails-to-deliver
On 31 Jul 2026, 2,807 shares of EWTX failed to deliver (about $115K).
Source: SEC fails-to-deliver (CNS) data